These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29153890)

  • 1. Molecular dynamics-assisted pharmacophore modeling of caspase-3-isatin sulfonamide complex: Recognizing essential intermolecular contacts and features of sulfonamide inhibitor class for caspase-3 binding.
    Kumar SP; Patel CN; Jha PC; Pandya HA
    Comput Biol Chem; 2017 Dec; 71():117-128. PubMed ID: 29153890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
    Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
    J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.
    Chu W; Rothfuss J; Chu Y; Zhou D; Mach RH
    J Med Chem; 2009 Apr; 52(8):2188-91. PubMed ID: 19326941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors.
    Firoozpour L; Gao L; Moghimi S; Pasalar P; Davoodi J; Wang MW; Rezaei Z; Dadgar A; Yahyavi H; Amanlou M; Foroumadi A
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1674-1684. PubMed ID: 32842789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
    Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-level structure-based pharmacophore modelling of caspase-3-non-peptide complexes: Extracting essential pharmacophore features and its application to virtual screening.
    Kumar SP; Jha PC
    Chem Biol Interact; 2016 Jul; 254():207-20. PubMed ID: 27291469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective nonpeptide inhibitors of caspases 3 and 7.
    Lee D; Long SA; Murray JH; Adams JL; Nuttall ME; Nadeau DP; Kikly K; Winkler JD; Sung CM; Ryan MD; Levy MA; Keller PM; DeWolf WE
    J Med Chem; 2001 Jun; 44(12):2015-26. PubMed ID: 11384246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.
    Chu W; Zhang J; Zeng C; Rothfuss J; Tu Z; Chu Y; Reichert DE; Welch MJ; Mach RH
    J Med Chem; 2005 Dec; 48(24):7637-47. PubMed ID: 16302804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes.
    Kumar SP; Jha PC
    Comb Chem High Throughput Screen; 2018; 21(1):26-40. PubMed ID: 29295689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
    Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
    Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone-chalcone and isatin-chalcone inhibitors probing the S2 active site pocket.
    Allangba KNPG; Keita M; Kre N'Guessan R; Megnassan E; Frecer V; Miertus S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):547-561. PubMed ID: 30696325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
    Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
    Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.
    Zhou D; Chu W; Chen DL; Wang Q; Reichert DE; Rothfuss J; D'Avignon A; Welch MJ; Mach RH
    Org Biomol Chem; 2009 Apr; 7(7):1337-48. PubMed ID: 19300818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors.
    Wang Q; Mach RH; Reichert DE
    J Chem Inf Model; 2009 Aug; 49(8):1963-73. PubMed ID: 19610597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.
    Lee D; Long SA; Adams JL; Chan G; Vaidya KS; Francis TA; Kikly K; Winkler JD; Sung CM; Debouck C; Richardson S; Levy MA; DeWolf WE; Keller PM; Tomaszek T; Head MS; Ryan MD; Haltiwanger RC; Liang PH; Janson CA; McDevitt PJ; Johanson K; Concha NO; Chan W; Abdel-Meguid SS; Badger AM; Lark MW; Nadeau DP; Suva LJ; Gowen M; Nuttall ME
    J Biol Chem; 2000 May; 275(21):16007-14. PubMed ID: 10821855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compressed images for affinity prediction-2 (CIFAP-2): an improved machine learning methodology on protein-ligand interactions based on a study on caspase 3 inhibitors.
    Erdas O; Andac CA; Gurkan-Alp AS; Alpaslan FN; Buyukbingol E
    J Enzyme Inhib Med Chem; 2015; 30(5):809-15. PubMed ID: 25578823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.
    Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M
    Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
    Chaudhuri A; Hudait N; Chakraborty SS
    Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents.
    Limpachayaporn P; Schäfers M; Schober O; Kopka K; Haufe G
    Bioorg Med Chem; 2013 Apr; 21(7):2025-36. PubMed ID: 23411396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies.
    Patel S; Modi P; Chhabria M
    J Mol Graph Model; 2018 May; 81():106-115. PubMed ID: 29549805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.